Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT05587062 · COMPLETED
Trial details
- NCT number
- NCT05587062
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2022-07-31
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.